{"date":"2025-06-10","count":31,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6838-2025-06-10-2133-79wkzb","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-06-10","time":"21:33:46","subject":"公告本公司授權夥伴向以色列衛生部申請眼部術後炎症和疼痛治療新藥APP13007上市查驗登記","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-06-10 21:33，「公告本公司授權夥伴向以色列衛生部申請眼部術後炎症和疼痛治療新藥APP13007上市查驗登記」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-06-10-2103-1hb5j80","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"21:03:35","subject":"合一ON101乳膏用於治療與預防放射線皮膚炎作用機制，獲國際SCI期刊Life Sciences接受並發表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-06-10 21:03，「合一ON101乳膏用於治療與預防放射線皮膚炎作用機制，獲國際SCI期刊Life Sciences接受並發表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-06-10-1924-f10y4x","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"19:24:35","subject":"美國FDA今日核准合一Bonvadis乳膏用於全皮層慢性傷口適應症的美國上市許可，達成國際商化重要里程碑。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-06-10 19:24，「美國FDA今日核准合一Bonvadis乳膏用於全皮層慢性傷口適應症的美國上市許可，達成國際商化重要里程碑。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-06-10-1843-1oysh57","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"18:43:24","subject":"公告本公司法人董事及其代表人辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-06-10 18:43，「公告本公司法人董事及其代表人辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-06-10-1830-1hq3kke","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"18:30:13","subject":"代重要子公司新普利股份有限公司公告董事會決議113年度盈餘分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-06-10 18:30，「代重要子公司新普利股份有限公司公告董事會決議113年度盈餘分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-06-10-1829-kd3ziw","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"18:29:28","subject":"本公司董事會決議發行114年度員工認股權憑證","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-06-10 18:29，「本公司董事會決議發行114年度員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-06-10-1825-t6rqxo","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"18:25:56","subject":"公告本公司114年股東常會重要決議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-06-10 18:25，「公告本公司114年股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-06-10-1820-738d33","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"18:20:24","subject":"(更正)公告本公司董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-06-10 18:20，「(更正)公告本公司董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-06-10-1809-2l8sfl","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"18:09:16","subject":"公告本公司114年股東常會全面改選董事(含獨立董事)當選名單(補充)","clause":"第6款","fact_date":"2025-06-10","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-06-10 18:09，「公告本公司114年股東常會全面改選董事(含獨立董事)當選名單(補充)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2025-06-10-1806-1s3jlig","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-06-10","time":"18:06:02","subject":"公告本公司董事長訂定除息基準日暨現金股利發放日","clause":"第31款","fact_date":"2025-06-10","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2025-06-10 18:06，「公告本公司董事長訂定除息基準日暨現金股利發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-06-10-1745-tc88vo","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"17:45:28","subject":"公告本公司新任審計委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-06-10 17:45，「公告本公司新任審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-06-10-1745-qxc1yk","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"17:45:04","subject":"公告本公司114年股東常會決議解除新任獨立董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-06-10 17:45，「公告本公司114年股東常會決議解除新任獨立董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-06-10-1744-fp68zp","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"17:44:42","subject":"公告本公司114年股東常會補選一席獨立董事當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-06-10 17:44，「公告本公司114年股東常會補選一席獨立董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-06-10-1744-ds864w","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"17:44:27","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-06-10 17:44，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6549-2025-06-10-1724-1asmasq","company_id":"6549","company":"景凱","market":"興櫃","industry":"生技醫療","date":"2025-06-10","time":"17:24:04","subject":"本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-10","cite_as":"公開資訊觀測站重大訊息：景凱（6549），2025-06-10 17:24，「本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-06-10-1723-762yry","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"17:23:42","subject":"本公司一一四年現金增資股款催繳公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-06-10 17:23，「本公司一一四年現金增資股款催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-06-10-1722-azoph0","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-06-10","time":"17:22:27","subject":"本公司完成向美國FDA呈送Pegargiminase(ADI-PEG 20)生物製劑用於治療惡性肺間皮癌的上市許可證申請案(BLA)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-06-10 17:22，「本公司完成向美國FDA呈送Pegargiminase(ADI-PEG 20)生物製劑用於治療惡性肺間皮癌的上市許可證申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6649-2025-06-10-1717-ds864w","company_id":"6649","company":"台生材","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"17:17:32","subject":"公告本公司114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-10","cite_as":"公開資訊觀測站重大訊息：台生材（6649），2025-06-10 17:17，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-06-10-1637-54swv6","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-06-10","time":"16:37:00","subject":"公告本公司法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-06-10 16:37，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-06-10-1630-738d33","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"16:30:14","subject":"(更正)公告本公司董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-06-10 16:30，「(更正)公告本公司董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-06-10-1619-qrsqda","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"16:19:04","subject":"公告本公司獨立董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-06-10 16:19，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2025-06-10-1540-1xl7hsd","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2025-06-10","time":"15:40:27","subject":"本公司受邀參加元富證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-06-12","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2025-06-10 15:40，「本公司受邀參加元富證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2025-06-10-1504-1e0dc6","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2025-06-10","time":"15:04:50","subject":"公告本公司114年股東常會決議解除董事競業限制案。","clause":"第22款","fact_date":"2025-06-10","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2025-06-10 15:04，「公告本公司114年股東常會決議解除董事競業限制案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6973-2025-06-10-1500-ds864w","company_id":"6973","company":"永立榮","market":"興櫃","industry":"生技醫療","date":"2025-06-10","time":"15:00:58","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-10","cite_as":"公開資訊觀測站重大訊息：永立榮（6973），2025-06-10 15:00，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-06-10-1444-1ifbulk","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"14:44:30","subject":"公告本公司董事會推選副董事長","clause":"第6款","fact_date":"2025-06-10","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-06-10 14:44，「公告本公司董事會推選副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-06-10-1443-ytq5mj","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"14:43:58","subject":"公告本公司推選第十一屆董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-06-10 14:43，「公告本公司推選第十一屆董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-06-10-1443-1mojk83","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"14:43:39","subject":"公告本公司114年股東常會解除董事及其代表人競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-06-10 14:43，「公告本公司114年股東常會解除董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-06-10-1443-1h3gsb1","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"14:43:00","subject":"公告本公司114年股東常會改選董事及獨立董事當選情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-06-10 14:43，「公告本公司114年股東常會改選董事及獨立董事當選情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-06-10-1441-d9bwy4","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"14:41:37","subject":"公告本公司114年度股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-06-10 14:41，「公告本公司114年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2025-06-10-1411-7unzat","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"14:11:03","subject":"本公司吸入伊洛前列素微脂體新藥L608臨床一期試驗成果，獲邀2025年度歐洲風濕病醫學年會（EULAR 2025）口頭報告","clause":"第12款","fact_date":"2025-06-11","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2025-06-10 14:11，「本公司吸入伊洛前列素微脂體新藥L608臨床一期試驗成果，獲邀2025年度歐洲風濕病醫學年會（EULAR 2025）口頭報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2025-06-10-1348-1o6yklr","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2025-06-10","time":"13:48:36","subject":"公告本公司一一四年度股東常會重要決議事項","clause":"第18款","fact_date":"2025-06-10","cite_as":"公開資訊觀測站重大訊息：精華（1565），2025-06-10 13:48，「公告本公司一一四年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}